Lay summary
We have assembled a national team of experts, plus a broad stakeholder group and international advisory panel, to investigate the clinical trials landscape across Aotearoa New Zealand.
We will utilise existing data sources plus direct retrieval from organisations undertaking clinical trials to identifiy clinical trial activity, capability in clinical trial design, execution, resourcing, translation and implementation, and how this activity and capability are positioned and accessed across geographical, social and ethnic domains in Aotearoa New Zealand. These findings will be synthesised with in-depth review of international evidence and best practice, leading to the development of evidence-informed recommendations on how Aotearoa New Zealand can develop a national, equitable, sustainable and embedded clinical trials enterprise. Such an enterprise will enhance the visibility of clinical trials within a learning healthcare system, increasing equity of access to clinical trials and contributing to improved and more equitable health outcomes for New Zealanders.